- Home
- IPSC vs LSF Comparison
IPSC vs LSF Comparison
Compare IPSC & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- LSF
- Stock Information
- Founded
- IPSC 2019
- LSF 2015
- Country
- IPSC United States
- LSF United States
- Employees
- IPSC N/A
- LSF N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- LSF Packaged Foods
- Sector
- IPSC Health Care
- LSF Consumer Staples
- Exchange
- IPSC Nasdaq
- LSF Nasdaq
- Market Cap
- IPSC 62.1M
- LSF 71.7M
- IPO Year
- IPSC 2021
- LSF 2020
- Fundamental
- Price
- IPSC $0.73
- LSF $7.27
- Analyst Decision
- IPSC Strong Buy
- LSF Strong Buy
- Analyst Count
- IPSC 5
- LSF 2
- Target Price
- IPSC $11.00
- LSF $7.75
- AVG Volume (30 Days)
- IPSC 493.4K
- LSF 59.9K
- Earning Date
- IPSC 03-13-2025
- LSF 02-26-2025
- Dividend Yield
- IPSC N/A
- LSF N/A
- EPS Growth
- IPSC N/A
- LSF N/A
- EPS
- IPSC N/A
- LSF N/A
- Revenue
- IPSC $2,684,000.00
- LSF $40,896,326.00
- Revenue This Year
- IPSC $230.60
- LSF $27.95
- Revenue Next Year
- IPSC $31.83
- LSF $21.07
- P/E Ratio
- IPSC N/A
- LSF N/A
- Revenue Growth
- IPSC 7.88
- LSF 20.33
- 52 Week Low
- IPSC $0.68
- LSF $0.71
- 52 Week High
- IPSC $5.51
- LSF $10.90
- Technical
- Relative Strength Index (RSI)
- IPSC 30.98
- LSF 46.79
- Support Level
- IPSC $0.72
- LSF $6.89
- Resistance Level
- IPSC $0.82
- LSF $7.72
- Average True Range (ATR)
- IPSC 0.06
- LSF 0.47
- MACD
- IPSC 0.01
- LSF -0.01
- Stochastic Oscillator
- IPSC 27.43
- LSF 32.97
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.